Avenna is a healthtech startup specialising in precision medicine solutions to enable early detection, mitigation and treatment of chronic inflammatory diseases. CIDs are a wide range of health conditions driven or accompanied by chronic inflammatory processes. CIDs are a major cause of sickness and premature death globally and are incredibly costly to a society.
Our GlyHealth technology for early detection and tracking of CI processes coupled with novel anti-inflammatory programmes gives us a chance revolutionise how healthcare for CID is performed.
healthtech, biotech, precision medicine, CIDs
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Avenna? We’re happy to assist you with our Startup Sourcing service.